viokace
Generic: pancrelipase
Labeler: aimmune therapeutics, inc.Drug Facts
Product Profile
Brand Name
viokace
Generic Name
pancrelipase
Labeler
aimmune therapeutics, inc.
Dosage Form
TABLET
Routes
Active Ingredients
pancrelipase amylase 78300 [USP'U]/1, pancrelipase lipase 20880 [USP'U]/1, pancrelipase protease 78300 [USP'U]/1
Manufacturer
Identifiers & Regulatory
Product NDC
73562-208
Product ID
73562-208_95ece3e2-a51f-4f4c-81ec-71aa2930a158
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
BLA
Application Number
BLA022542
Listing Expiration
2026-12-31
Marketing Start
2021-03-01
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
73562208
Hyphenated Format
73562-208
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
viokace (source: ndc)
Generic Name
pancrelipase (source: ndc)
Application Number
BLA022542 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 78300 [USP'U]/1
- 20880 [USP'U]/1
Packaging
- 1 BOTTLE in 1 CARTON (73562-208-10) / 100 TABLET in 1 BOTTLE
Packages (1)
Ingredients (3)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "95ece3e2-a51f-4f4c-81ec-71aa2930a158", "openfda": {"unii": ["8MYC33932O", "3560D81V50", "YOJ58O116E"], "rxcui": ["1247379", "1247381", "1247386", "1247388"], "spl_set_id": ["58bdb8de-582d-44e6-9b72-8d5a42fdf501"], "manufacturer_name": ["Aimmune Therapeutics, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (73562-208-10) / 100 TABLET in 1 BOTTLE", "package_ndc": "73562-208-10", "marketing_start_date": "20210301"}], "brand_name": "Viokace", "product_id": "73562-208_95ece3e2-a51f-4f4c-81ec-71aa2930a158", "dosage_form": "TABLET", "product_ndc": "73562-208", "generic_name": "Pancrelipase", "labeler_name": "Aimmune Therapeutics, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Viokace", "active_ingredients": [{"name": "PANCRELIPASE AMYLASE", "strength": "78300 [USP'U]/1"}, {"name": "PANCRELIPASE LIPASE", "strength": "20880 [USP'U]/1"}, {"name": "PANCRELIPASE PROTEASE", "strength": "78300 [USP'U]/1"}], "application_number": "BLA022542", "marketing_category": "BLA", "marketing_start_date": "20210301", "listing_expiration_date": "20261231"}